Should all eligible patients with multiple myeloma receive autologous stem-cell transplant as part of initial treatment?

被引：10
|
作者：
Moreau, Philippe [1 ]
Rajkumar, S. Vincent [2 ]
机构：
[1] Univ Hosp Hotel Dieu, F-44093 Nantes, France
[2] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
来源：
LEUKEMIA RESEARCH | 2012年 / 36卷 / 06期
关键词：
HIGH-DOSE THERAPY; STANDARD CHEMOTHERAPY; RANDOMIZED-TRIAL; DEXAMETHASONE; THALIDOMIDE; BORTEZOMIB; CONSOLIDATION; RESCUE;
D O I：
10.1016/j.leukres.2012.02.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：677 / 681
页数：5
相关论文
共 50 条
  • [31] Autologous stem cell transplant for multiple myeloma patients 70 years or older
    E Muchtar
    D Dingli
    S Kumar
    F K Buadi
    A Dispenzieri
    S R Hayman
    R C Wolf
    D A Gastineau
    R Chakraborty
    W J Hogan
    N Leung
    P Kapoor
    M Q Lacy
    S V Rajkumar
    M A Gertz
    Bone Marrow Transplantation, 2016, 51 : 1449 - 1455
  • [32] Results of autologous stem cell transplant in multiple myeloma patients with renal failure
    Badros, A
    Barlogie, B
    Siegel, E
    Roberts, J
    Langmaid, C
    Zangari, M
    Desikan, R
    Shaver, MJ
    Fassas, A
    McConnell, S
    Muwalla, F
    Barri, Y
    Anaissie, E
    Munshi, N
    Tricot, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 822 - 829
  • [33] Outcome of Patients with Multiple Myeloma by Ethnicity in the Setting of Autologous Stem Cell Transplant
    Sasaki, Koji
    Bashir, Qaiser
    Shah, Nina
    Hosing, Chitra
    Popat, Uday R.
    Nieto, Yago
    Parmar, Simrit
    Shah, Jatin
    Weber, Donna
    Thomas, Sheeba
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S231 - S232
  • [34] RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANT IN MULTIPLE MYELOMA PATIENTS WITH RENAL FAILURE
    Ben Abdeljelil, N.
    Torjemane, L.
    Lakhal, A.
    Elfatmi, R.
    Ladeb, S.
    Ben Othman, T.
    HAEMATOLOGICA, 2014, 99 : 656 - 656
  • [35] Continuous Treatment with Lenalidomide Improves Outcomes in Newly Diagnosed Myeloma Patients Not Eligible for Autologous Stem Cell Transplant: Results of the Myeloma XI Trial
    Pawlyn, C.
    Davies, F.
    Cairns, D.
    Striha, A.
    Best, P.
    Sigsworth, R.
    Jones, J.
    Kishore, B.
    Garg, M.
    Williams, C.
    Karunanithi, K.
    Lindsay, J.
    Jenner, M.
    Cook, G.
    Kaiser, M.
    Drayson, M.
    Owen, R.
    Russell, N.
    Gregory, W.
    Jackson, G.
    Morgan, G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 15 - 16
  • [36] Continuous Treatment with Lenalidomide Improves Outcomes in Newly Diagnosed Myeloma Patients Not Eligible for Autologous Stem Cell Transplant: Results of the Myeloma XI Trial
    Pawlyn, Charlotte
    Davies, Faith E.
    Cairns, David
    Striha, Alina
    Best, Phillip
    Sigsworth, Rachel
    Jones, John R.
    Kishore, Bhuvan
    Garg, Mamta
    Williams, Cathy
    Karunanithi, Kamaraj
    Lindsay, Jindriska
    Jenner, Matthew W.
    Cook, Gordon
    Kaiser, Martin F.
    Drayson, Mark T.
    Owen, Roger G.
    Russell, Nigel H.
    Gregory, Walter M.
    Jackson, Graham
    Morgan, Gareth J.
    BLOOD, 2017, 130
  • [37] Treatment of Transplant-Eligible Patients with Multiple Myeloma in 2014
    Landau, Heather
    Giralt, Sergio
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (05) : 815 - +
  • [38] Treatment Pattern and Overall Survival in Newly Diagnosed Multiple Myeloma Patients who are not Eligible for Autologous Stem Cell Transplantation
    He, Jianming
    Qiu, Lugui
    Schmerold, Luke
    Potluri, Ravi
    Li, Lin
    Hu, Peter
    Nemat, Sepideh
    Smugar, Steven S.
    Appiani, Carlos
    Mehra, Maneesha
    Richarz, Ute
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E229 - E229
  • [39] HEMATOPOIETIC STEM-CELL TRANSPLANT FOR MULTIPLE-MYELOMA (MM)
    BARLOGIE, B
    LEUKEMIA, 1993, 7 (07) : 1095 - 1095
  • [40] Allogeneic stem-cell transplantation for early relapse of multiple myeloma after autologous stem-cell transplantation
    Schmidt, V
    Mugge, L-O
    Klink, A.
    Hilgendorf, I
    Hochhaus, A.
    Sayer, H. G.
    Oncology Research and Treatment, 2015, 38 : 128 - 129
12345